Give Online: Help shape patient care for generations to come.
Cleveland Clinic Logo

Nima Sharifi, MD

Nima Sharifi, MD

Appointed: 2013

No Patient Satisfaction Reviews
Nima Sharifi, MD
Department: Cancer Biology
Location: Cleveland Clinic Main Campus
Mail Code NB40
9500 Euclid Avenue
Cleveland, OH 44195
Nima Sharifi, MD
Department: Hematology and Oncology
Location: Cleveland Clinic Main Campus
Mail Code NB40
9500 Euclid Avenue
Cleveland, OH 44195
Nima Sharifi, MD
Department: Urology
Location: Cleveland Clinic Main Campus
Mail Code NB40
9500 Euclid Avenue
Cleveland, OH 44195
Type of Doctor:

Professional Highlights

Kendrick Family Endowed Chair for Prostate Cancer Research
Prostate Cancer Research Laboratory Website

Education & Fellowships

Fellowship - National Cancer Institute
Medical Oncology
Bethesda, MD USA
Residency - Yale-New Haven Hospital
Internal Medicine
New Haven, CT USA
Medical School - University of Pittsburgh School of Medicine
Pittsburgh, PA USA
Undergraduate - Virginia Polytechnic Institute and State University
Blacksburg, VA USA


  • Internal Medicine- Medical Oncology

Awards & Honors

  • 2014 American Association for Cancer Research Award for Outstanding Achievement in Cancer Research
  • 2014 Elected Member, American Society for Clinical Investigation
  • 2013 National Cancer Institute R01CA168899
  • 2012 National Cancer Institute R01CA172382
  • 2012 American Cancer Society Research Scholar Award
  • 2009 Howard Hughes Medical Institute Physician-Scientist Early Career Award
  • 2008 Prostate Cancer Foundation Young Investigator Award

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 4/11/2016, Dr. Sharifi has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Sharifi receives fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Astellas Scientific and Medical Affairs, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English